Puneet Souda
Stock Analyst at Leerink Partners
(1.58)
# 3,264
Out of 4,931 analysts
215
Total ratings
47.43%
Success rate
-1.7%
Average return
Main Sectors:
Stocks Rated by Puneet Souda
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CYRX Cryoport | Upgrades: Outperform | $16 | $8.49 | +88.46% | 7 | Aug 6, 2025 | |
| MASS 908 Devices | Upgrades: Outperform | $12 | $6.42 | +86.92% | 7 | Aug 5, 2025 | |
| QTRX Quanterix | Downgrades: Market Perform | $12 → $8 | $4.59 | +74.29% | 12 | Apr 30, 2025 | |
| NEO NeoGenomics | Downgrades: Market Perform | $25 → $9 | $5.80 | +55.17% | 10 | Apr 30, 2025 | |
| HOLX Hologic | Downgrades: Market Perform | $80 → $75 | $67.90 | +10.46% | 7 | Feb 6, 2025 | |
| MYGN Myriad Genetics | Downgrades: Market Perform | $30 → $21 | $6.30 | +233.33% | 7 | Dec 9, 2024 | |
| VCYT Veracyte | Maintains: Outperform | $35 → $40 | $27.65 | +44.67% | 14 | Oct 17, 2024 | |
| NTRA Natera | Maintains: Outperform | $140 → $150 | $159.71 | -6.08% | 7 | Oct 17, 2024 | |
| WAT Waters | Upgrades: Outperform | $325 → $375 | $278.00 | +34.89% | 15 | Aug 1, 2024 | |
| TMO Thermo Fisher Scientific | Maintains: Outperform | $630 | $455.85 | +38.20% | 19 | Jul 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $50 → $35 | $19.65 | +78.12% | 11 | Jun 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $170 → $145 | $113.98 | +27.22% | 19 | May 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $300 | $197.93 | +51.57% | 1 | May 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $249 → $250 | $95.99 | +160.46% | 19 | Feb 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $125 → $110 | $51.05 | +115.48% | 6 | Feb 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $70 → $75 | $44.03 | +70.36% | 16 | Jan 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $230 → $200 | $113.52 | +76.18% | 7 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $20 → $18 | $4.83 | +272.67% | 6 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $6 | $1.88 | +219.15% | 1 | Nov 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $45 → $30 | $25.52 | +17.55% | 6 | Nov 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $85 → $87 | $31.10 | +179.74% | 13 | May 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $170 → $140 | $51.97 | +169.39% | 5 | Feb 24, 2022 |
Cryoport
Aug 6, 2025
Upgrades: Outperform
Price Target: $16
Current: $8.49
Upside: +88.46%
908 Devices
Aug 5, 2025
Upgrades: Outperform
Price Target: $12
Current: $6.42
Upside: +86.92%
Quanterix
Apr 30, 2025
Downgrades: Market Perform
Price Target: $12 → $8
Current: $4.59
Upside: +74.29%
NeoGenomics
Apr 30, 2025
Downgrades: Market Perform
Price Target: $25 → $9
Current: $5.80
Upside: +55.17%
Hologic
Feb 6, 2025
Downgrades: Market Perform
Price Target: $80 → $75
Current: $67.90
Upside: +10.46%
Myriad Genetics
Dec 9, 2024
Downgrades: Market Perform
Price Target: $30 → $21
Current: $6.30
Upside: +233.33%
Veracyte
Oct 17, 2024
Maintains: Outperform
Price Target: $35 → $40
Current: $27.65
Upside: +44.67%
Natera
Oct 17, 2024
Maintains: Outperform
Price Target: $140 → $150
Current: $159.71
Upside: -6.08%
Waters
Aug 1, 2024
Upgrades: Outperform
Price Target: $325 → $375
Current: $278.00
Upside: +34.89%
Thermo Fisher Scientific
Jul 6, 2023
Maintains: Outperform
Price Target: $630
Current: $455.85
Upside: +38.20%
Jun 5, 2023
Maintains: Outperform
Price Target: $50 → $35
Current: $19.65
Upside: +78.12%
May 24, 2023
Maintains: Outperform
Price Target: $170 → $145
Current: $113.98
Upside: +27.22%
May 1, 2023
Initiates: Outperform
Price Target: $300
Current: $197.93
Upside: +51.57%
Feb 8, 2023
Maintains: Outperform
Price Target: $249 → $250
Current: $95.99
Upside: +160.46%
Feb 3, 2023
Maintains: Outperform
Price Target: $125 → $110
Current: $51.05
Upside: +115.48%
Jan 12, 2023
Maintains: Outperform
Price Target: $70 → $75
Current: $44.03
Upside: +70.36%
Jan 6, 2023
Maintains: Outperform
Price Target: $230 → $200
Current: $113.52
Upside: +76.18%
Jan 6, 2023
Maintains: Outperform
Price Target: $20 → $18
Current: $4.83
Upside: +272.67%
Nov 29, 2022
Initiates: Outperform
Price Target: $6
Current: $1.88
Upside: +219.15%
Nov 21, 2022
Maintains: Market Perform
Price Target: $45 → $30
Current: $25.52
Upside: +17.55%
May 5, 2022
Maintains: Outperform
Price Target: $85 → $87
Current: $31.10
Upside: +179.74%
Feb 24, 2022
Maintains: Outperform
Price Target: $170 → $140
Current: $51.97
Upside: +169.39%